Joint Medicines Formulary Formulary

	Joint Medicines Formulary
	Airedale NHS Foundation Trust Airedale, Wharfedale and Craven CCG

Search

Formulary Chapter 2: Cardiovascular system - Full Chapter

Notes:

Unless explicitly stated, any brand names included in brackets next to a drug's generic name are there solely to aid searching and identification, and should not be considered to limit use to that specific brand.

Details...

02.06.02

Calcium-channel blockers

Amlodipine

Formulary

Amlodipine Tablets

Nifedipine

Formulary

Nifedipine Capsules
Nifedipine MR Tablets

Diltiazem

Formulary

Diltiazem MR Capsules
Diltiazem MR Tablets

Please ensure the brand is specified on the prescription.

When prescribing long acting diltiazem for a new patient, please use either Diltiazem LA 180mg, 240mg or 300mg.
This allows the pharmacy to dispense the brand of diltiazem, which is cost-effective across primary and secondary care.

Patients who are admitted who are already taking LA diltiazem should be maintained on their current brand unless the dose is changed for other reasons.

Please note: Diliazem XL should only be prescribed once daily.

Felodipine

Restricted

Felodipine Tablets
Felodipine MR Tablets

Following recommendation of Consultant Cardiologist.

Lacidipine

Restricted

Lacidipine Tablets

Reserved for existing patients only.

Lercanidipine Hydrochloride

Formulary

Lercanidipine Hydrochloride Tablets

Nimodipine

Restricted

Nimodipine Tablets

Supported for the prevention and treatment of ischaemic neurological defects following aneurismal subarachnoid haemorrhage.

Verapamil Hydrochloride

Formulary

Verapamil Tablets
Green Traffic Light

Verapamil MR Capsules
Green Traffic Light

Verapamil SF Solution
Red Traffic Light

Verapamil Injection

UKMI Q&A: What is the evidence for verapamil for prevention of cluster headache? (September 2014)

UKMI QA: How should ankle oedema caused by calcium channel blockers be treated? (July 2013)

....

Non Formulary Items

Nimodipine (IV infusion)

Non Formulary

Nimodipine Infusion

Prevention and treatment of ischaemic neurological defects following aneurismal subarachnoid haemorrhage.

Non-formulary at ANHSFT due to the risk of serious side effects when given via IV adminstration. Nimodipine tablets are available for the same indication for administration by mouth, or via enteral feeding tubes (unlicensed use).

Key

	Notes
	Section Title (top level)
	Section Title (sub level)
	First Choice item
	Non Formulary section
	Restricted Drug
	Unlicensed
	Display tracking information
	Link to adult BNF
	Link to children's BNF
	Link to SPCs

	Cytotoxic Drug
	Controlled Drug
	High Cost Medicine
	Cancer Drugs Fund
	NHS England
	Homecare
	CCG

Traffic Light Status Information

Status	Description
	Green - Drugs suitable for generalised use in accordance with position summary. Inform primary care of need to prescribe using a TTO chart if in patient or Treatment Advice Note (TAN) if Outpatient.
	Amber - these drugs require specialist initiation or recommendation
	Amber Share Care - Drugs suitable for generalist use, in accordance with position summary, normally following specialist initiation and stabilisation. Ongoing division of responsibility for drug and disease monitoring between specialist and GP by a Shared Care Guideline (SCG). If no SCG in place status reverts to red.
	Red - Drugs for specialist use only, in accordance with position summary. GP’s should not be asked to prescribe these products.
	Red ULM - Unlicensed medicines for specialist use only, in accordance with position summary. GP’s should not be asked to prescribe these products.
	Grey drugs - No formal commissioning position. Check appropriate CCG /NHSE commissioning list or contact CCG/NHSE Medicines Management team for advice. Fill in individual funding request for appropriate CCG/NHSE. This will need to be signed by the Chief Pharmacist and a copy of the relevant DTC submission attached.
	Black - Drugs not routinely commissioned so should not usually be prescribed